Child’s Legacy Promises Support for Future Niemann-Pick Patients

July 27, 2016


Wylder Laffoon was just seven months old when his parents, Steven and Shannon Laffoon, learned their son had a rare, genetic disease that meant he would not live past age 3.

Wylder died when he was three years old in July 2012 of Niemann-Pick Type A, but his legacy lives on through the Wylder Nation Foundation. His parents founded the nonprofit to support doctors and researchers who are trying to find a cure for the disease.

“The mission is to improve the lives of children diagnosed with these rare diseases…and provide hope by accelerating the discovery and development of treatment options,” Steven Laffoon said.

578e671402896.imageThe foundation is donating funds to TGen, the Phoenix research initiative that is studying a group in Chile that carries the genetic markers for Niemann-Pick.

Niemann-Pick type A is the most severe type of the disease, causing children to die in early childhood. It causes children to grow an enlarged spleen and liver, dangerously slows their rate of growth, damages their lungs, and inhibits their mental abilities and mobility. There is no cure and death is guaranteed.

Niemann-Pick has three different types — type A, B, and C, (which can be split into C1 and C2. Type A and B are the more rare forms of the disease, although children who have type B can reach adulthood.

“At the root cause, they have a change in their DNA blueprint that affects an enzyme … something in the body that metabolizes the things we eat, for example, into other chemicals,” said Matt Huentelman, professor of neurogenomics at TGen. “And the defect in that enzyme forces the build up of something that is very toxic to the kids. And that ends up in…eventually, death for the kids.


Stay Connected

Sign up for updates straight to your inbox.